Autologous Cell Therapy Market Projected to Reach USD 34.7 Billion by 2027 with a CAGR of 18.1%
Aug 22, 2024
Biotechnology Equities
The Potential of AI in Drug Discovery Amplified: A Look at Recursion Pharmaceuticals' Prospects with Exscientia Merger
Aug 11, 2024
Eisai and Biogen's Joint Development, Lecanemab, Progresses in EU Regulatory Review for Alzheimer's Treatment
Jul 27, 2024
NurExone Biologic Targets Glaucoma with ExoPTEN in Pre-Clinical Study for Multi-Billion Dollar Market
Jun 30, 2024
Omega Therapeutics Welcomes Richard N. Kender to its Board of Directors
Jun 25, 2024
U.S National Institutes of Health Awards $1.4 Million Funding to Pluri for PLX-R18 Acute Radiation Syndrome Research
Jun 6, 2024
ADC Therapeutics SA Joins H.C. Wainwright BioConnect Investor Conference
May 16, 2024
Industrial Enzymes Market Projected to Reach USD 25.42 Billion by 2033, Flourishing at a 6.79% CAGR, Reveals Custom Market Insights
May 14, 2024
Senti Bio's Preclinical Data for SENTI-202 Shows Promising CAR-NK Therapy Against AML
May 1, 2024
Regeneron Teams Up with Mammoth Biosciences for Innovative CRISPR Gene Editing Advancements
Apr 25, 2024
Gain Therapeutics Announces Presentation at Public Ventures Discovery Day
Mar 16, 2024
Vigil Neuroscience to Exhibit at Stifel 2024 Virtual CNS Days
Mar 12, 2024
FDA Grants Breakthrough Therapy Designation to MindMed's LSD Treatment for Anxiety
Mar 8, 2024
Vigil Neuroscience Spotlight: VG-3927 as a New Hope in Alzheimer’s Disease Treatment
Mar 7, 2024
Anticipating Decline: ADC Therapeutics SA ADCT Braces for Q4 Earnings Release
Feb 20, 2024
Cathie Wood's Ark Invest Adjusts Tech Portfolio, Sells Nvidia and Buys Robinhood Shares
Feb 8, 2024
Synlogic Reveals Encouraging Data on SYNB1353 for Treating Homocystinuria
Feb 3, 2024
TC BioPharm CEO Bryan Kobel Discusses Company Outlook on 'The Big Biz Show'
Jan 30, 2024
iSpecimen Joins Forces with TriMetis Life Sciences to Advance Tissue-Based Research Through AI
Jan 24, 2024
Bionomics' Year in Review and Forward-Looking Plans for 2024
Jan 22, 2024
WuXi XDC and IntoCell Forge Strategic Partnership to Enhance ADC Development
Jan 3, 2024
ImmunoScape and MiNK Therapeutics Form Strategic Alliance to Enhance TCR-Therapeutic Discoveries
Dec 21, 2023
ADC Therapeutics Reports Promising Outcomes from ZYNLONTA® and Rituximab Combo Therapy in a Phase 2 Trial for Follicular Lymphoma
Dec 13, 2023
SCYNEXIS SCYX Downgraded to Hold Amidst Market Evaluations
Nov 18, 2023